Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...
A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the best to prescribe upfront—and to which patients. Over the past 14 years, ...
The MarketWatch News Department was not involved in the creation of this content. EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation ...
3don MSN
Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives
A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than ...
In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer. In a recent interview with CURE, Dr. Kai Tsao broke down current treatment ...
Increasing numbers of older US men with prostate cancer are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according ...
In metastatic prostate cancer, AI-facilitated quantification of metastatic burden, accurate identification of castration resistance, and prediction of treatment sensitivity and resistance are active ...
Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...
Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results